Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis

Carcinogenesis

Volumn 30, Issue 5, 2009, Pages 894-901

  Yu, Chunping ^a   Chen, Kun ^a   Zheng, Haiqing ^a   Guo, Xianzhi ^a   Jia, Weihua ^a   Li, Manzhi ^a   Zeng, Musheng ^a   Li, Jun ^b   Song, Libing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTE ELEVATED GENE 1 PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; UPREGULATION;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL ADHESION MOLECULES; DISEASE PROGRESSION; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; RNA, NEOPLASM; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 65549113479     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp064     Document Type: Article

References (38)

1. Kamangar,F. et al. (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. J. Clin. Oncol., 24, 2137-2150.
2. Parkin,D.M. et al. (2001) Cancer burden in the year 2000. The global picture. Eur. J. Cancer, 37, S4-S66.
3. Xing,D. et al. (2003) Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population. Oncol. Rep., 10, 1615-1623.
4. Hiyama,T. et al. (2007) Genetic polymorphisms and esophageal cancer risk. Int. J. Cancer, 121, 1643-1658.
5. Koshy,M. et al. (2004) Multiple management modalities in esophageal cancer: Combined modality management approaches. Oncologist, 9, 147-159.
6. Younes,M. et al. (2002) Incidence and survival trends of esophageal carcinoma in the United States: Racial and gender differences by histological type. Scand. J. Gastroenterol., 37, 1359-1365.
7. Lin,D.C. et al. (2009) Protein alterations in ESCC and clinical implications. Dis. Esophagus, 22, 9-20.
8. Yie,S.M. et al. (2007) Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am. J. Clin. Pathol. 128, 1002-1009.
9. Ashida,A. et al. (2006) Expression profiling of esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: Clinical implications. Int. J. Oncol., 28 1345-1352.
10. Kang,D.C. et al. (2005) Cloning and characterization of HIV-1 inducible astrocyte elevated gene-1, AEG-1. Gene, 353, 8-15.
11. Lee,S.G. et al. (2006) Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc. Natl Acad. Sci. USA, 103, 17390-17395.
12. Emdad,L. et al. (2007) Astrocyte elevated gene-1: Recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol. Ther., 114, 155-170.
13. Lee,S.G. et al. (2008) Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene, 27, 1114-1121.
14. Kikuno,N. et al. (2007) Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene, 26, 7647-7655.
15. Brown,D.M. et al. (2004) Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell, 5, 365-374.
16. Sarkar,D. et al. (2008) Molecular basis of NF-KB activation by astrocyte elevated gene-1. Cancer Res., 68, 1478-1484.
17. Li,J. et al. (2008) Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin. Cancer Res., 14, 3319-3326.
18. Andl,C.D. et al. (2003) Epidermal growth factor receptor mediates increased cell proliferation, migration, and aggregation in esophageal keratinocytes in vitro and in vivo. J. Biol. Chem., 278, 1824-1830.
19. Sobin,L.H. et al. (1997) International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th edn. New York, NY: Wiley. pp. 54-58.
20. Livak,K.J. et al. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods, 25, 402-408.
21. Parkin,D.M. et al. (1993) Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer, 54, 1-13.
22. An,J.Y. et al. (2004) Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province. World J. Gastroenterol., 10, 3365-3368.
23. Lu,S.M. et al. (2008) Characterization of one newly established esophageal cancer cell line CSEC from a high-incidence area in China. Dis. Esophagus, 21, 309-315.
24. Yang,L. et al. (2003) Time trend in cancer mortality in China, 1987-1999. Int. J. cancer, 106, 771-783.
25. Mandard,A.M. et al. (2000) Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat. Res., 462, 335-342.
26. Lehrbach,D.M. et al. (2003) Molecular aspects of esophageal squamous cell carcinoma carcinogenesis. Arq. Gastroenterol., 40 256-261.
27. Li,B.in et al. (2007) Id-1 activation of PI3K/Akt/NFkB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis, 28, 2313-2320.
28. Tian,F. et al. (2006) Nuclear factor-κB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim. Biophys. Sin., 38, 318-326.
29. Chen,L.F. et al. (2004) Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol., 5, 392-401.
30. Perkins,N.D. (2007) Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol., 8, 49-62.
31. Emdad,L. et al. (2006) Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: Implications for tumor progression and metastasis. Cancer Res., 66, 1509-1516.
32. Sarkar,D. et al. (2008) Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res., 68, 1478-1484.
33. Freedman,N.D. et al. (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am. J. epidemiol., 165, 1424-1433.
34. Nasrollahzadeh,D. et al. (2008) Opium, tobacco, and alcohol use in relation to oesophageal squamous cell carcinoma in a high-risk area of Iran. Br. J. Cancer, 98, 1857-1863.
35. Gao,Y.T. et al. (1994) Risk factor for esophageal cancer in Shanghai, China. I. Role of cigarette smoking and alcohol drinking. Int. J. Cancer, 58, 192-196.
36. Fan,Y. et al. (2008) Alcohol, tobacco, and diet in relation to esophageal cancer: The Shanghai Cohort Study. Nutr. Cancer, 60 354-363.
37. Hecht,S.S. et al. (1996) Lung, and esophageal carcinogenesis. In: Aisner,J., Arriagada,R., Green,M.R., Martini,N., Perry,M.C. (eds) Comprehensive Textbook of Thoracic Oncology. Baltimore, MD: Williams's and Wilkins, pp. 25-50.
38. Stoner,G.D. et al. (2007) Chemoprevention of esophageal squamous cell carcinoma. Toxicol. Appl. Pharmacol., 224, 337-349.